Long‐term binding of Aβ peptides to PRPs induces enhanced release of pro‐inflammatory cytokines in microglia, such as IL‐1β and TNF‐α, which could promote the progression of AD (Q. Li et al., 2018). Here, IL1B is linked to Alzheimer disease.